Atezolizumab (Tecentriq) combined with carboplatin has shown signs of clinical activity in women with metastatic invasive lobular breast cancer (ILC).
Medscape Medical News
GELATO: Chemoimmunotherapy in Invasive Lobular Breast Cancer
Atezolizumab (Tecentriq) combined with carboplatin has shown signs of clinical activity in women with metastatic invasive lobular breast cancer (ILC).
Medscape Medical News
